We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Hexcel
HXL
$7.76B
| $6.28M | 0.01% |
115,189
+6,790
| +6% | +$357K |
|
877
AXIS Capital
AXS
$7.67B
| $6.28M | 0.01% |
93,641
+5,548
| +6% | +$372K |
|
|
WFT
878
DELISTED
Weatherford International plc
WFT
| $6.25M | 0.01% |
939,719
+80,693
| +9% | +$473K |
|
879
Healthcare Services Group
HCSG
$1.58B
| $6.24M | 0.01% |
144,802
+40,958
| +39% | +$1.68M |
|
880
Silicon Laboratories
SLAB
$7.15B
| $6.18M | 0.01% |
84,077
+2,102
| +3% | +$147K |
|
881
Glacier Bancorp
GBCI
$6.38B
| $6.18M | 0.01% |
182,232
+55,637
| +44% | +$1.97M |
|
|
ZAYO
882
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $6.17M | 0.01% |
187,418
+12,053
| +7% | +$384K |
|
883
Nu Skin
NUS
$254M
| $6.16M | 0.01% |
110,829
+41,216
| +59% | +$2.12M |
|
|
VISN
884
Vistance Networks Inc
VISN
$2.64B
| $6.14M | 0.01% |
147,146
+6,747
| +5% | +$260K |
|
885
NorthWestern Energy
NWE
$4.29B
| $6.11M | 0.01% |
103,996
+4,900
| +5% | +$281K |
|
886
Dana Inc
DAN
$2.91B
| $6.1M | 0.01% |
315,946
+6,814
| +2% | +$132K |
|
|
CMD
887
DELISTED
Cantel Medical Corporation
CMD
| $6.1M | 0.01% |
76,123
+5,949
| +8% | +$473K |
|
888
Regal Rexnord
RRX
$13.5B
| $6.09M | 0.01% |
80,492
+3,008
| +4% | +$222K |
|
889
Sally Beauty Holdings
SBH
$1.46B
| $6.08M | 0.01% |
297,378
+19,853
| +7% | +$454K |
|
890
Rithm Capital
RITM
$5.51B
| $6.07M | 0.01% |
357,578
+64,636
| +22% | +$1.06M |
|
891
EastGroup Properties
EGP
$11.3B
| $6.06M | 0.01% |
82,415
+21,241
| +35% | +$1.55M |
|
892
XPO
XPO
$23.4B
| $6.06M | 0.01% |
365,894
+18,484
| +5% | +$302K |
|
893
Dycom Industries
DY
$12.5B
| $6.05M | 0.01% |
65,110
+1,447
| +2% | +$123K |
|
|
FCE.A
894
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $6.05M | 0.01% |
277,881
+28,472
| +11% | +$630K |
|
895
Sprouts Farmers Market
SFM
$8.17B
| $6.04M | 0.01% |
261,264
+4,392
| +2% | +$86.1K |
|
896
Belden
BDC
$4.56B
| $6.02M | 0.01% |
86,994
+2,603
| +3% | +$191K |
|
|
JOY
897
DELISTED
Joy Global Inc
JOY
| $6.02M | 0.01% |
212,980
+7,980
| +4% | +$225K |
|
898
Qiagen
QGEN
$8.55B
| $6.01M | 0.01% |
195,742
+12,856
| +7% | +$396K |
|
899
First Financial Bankshares
FFIN
$5B
| $6M | 0.01% |
299,432
+94,908
| +46% | +$2.03M |
|
900
ABM Industries
ABM
$2.79B
| $6M | 0.01% |
137,501
+32,640
| +31% | +$1.35M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.